Stroke Trial, Recruiting NCT07366697 Sponsor: KU Leuven Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT07366697
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have given written consent before any study procedures take place
  • People aged between 18 and 80 years old (inclusive)
  • People who have had a stroke on one side of the brain, affecting the upper or lower brain regions (confirm with trial site)
  • People who are at least 6 months past their stroke at the time of joining
  • People who have been discharged from hospital and are currently living at home in the community
  • People who are able and willing to wear small motion-tracking devices on both wrists for three days in a row
  • People who have a noticeable difficulty using both arms and hands together, as observed during assessment

Who may not be able to join:

  • People with very severe weakness or loss of movement in the arm and hand, based on a specific assessment score (confirm with trial site)
  • People with significant difficulties with thinking or understanding language that would make it hard to follow study instructions or complete tasks, as determined during screening
  • People who have other conditions affecting the brain, nervous system, or bones and joints that also affect how the arms work — for example, Parkinson's disease, multiple sclerosis, severe joint disease, or a nerve injury in the shoulder or arm

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Geert Verheyden, KU Leuven

Phone: +32 16 32 91 16

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
KU Leuven
Registry
ClinicalTrials.gov
Start date
10 December 2025
Est. completion
1 June 2026

Where this trial is recruiting

🇧🇪 Belgium

Primary endpoints

Correlation between Ad-AHA Stroke total score and accelerometer-derived Use Ratio

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov